Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle

Injectable alginate hydrogel for enhanced spatiotemporal control of lentivector delivery in murine skeletal muscle

Author Stilhano, Roberta S. Autor UNIFESP Google Scholar
Madrigal, Justin L. Google Scholar
Wong, Kevin Google Scholar
Williams, Priscilla A. Google Scholar
Martin, Priscila K. M. Autor UNIFESP Google Scholar
Yamaguchi, Fabio S. M. Google Scholar
Samoto, Vivian Y. Autor UNIFESP Google Scholar
Han, Sang W. Autor UNIFESP Google Scholar
Silva, Eduardo A. Google Scholar
Abstract Hydrogels are an especially appealing class of biomaterials for gene delivery vehicles as they can be introduced into the body with minimally invasive procedures and are often applied in tissue engineering and regenerative medicine strategies. In this study, we show for the first time the use of an injectable alginate hydrogel for controlled delivery of lentivectors in the skeletal muscle of murine hindlimb. We propose to alter the release rates of lentivectors through manipulation of the molecular weight distribution of alginate hydrogels. The release of lentivector was tested using two different ratios of low and high molecular weight (MW) alginate polymers (75/25 and 25/75 low/high MW). The interdependency of lentivector release rate and alginate degradation rate was assessed in vitro. Lentivector-loaded hydrogels maintained transduction potential for up to one week in vitro as demonstrated by the continual transduction of HEK-293T cells. Injection of lentivector-loaded hydrogel in vivo led to a sustained level of transgene expression for more than two months while minimizing the copies of lentivirus genome inserted into the genome of murine skeletal muscle cells. This strategy of spatiotemporal control of lentivector delivery from alginate hydrogels may provide a versatile tool to combine gene therapy and biomaterials for applications in regenerative medicine. (C) 2016 Elsevier B.V. All rights reserved.
Keywords Gene therapy
Sustained gene delivery
Biodegradable gels
Tissue engineering
Regenerative medicine
Language English
Sponsor University of California, Davis
FAPESP-Sao Paulo, Brazil
American Heart Association
Hellman Family
FAPESP scholarship
HHMI Integrating Medicine into Basic Science fellowship
Grant number FAPESP: 2015/20206-8
AHA: 15BGIA25730057
FAPESP scholarship: 2012/00,753-6
Date 2016
Published in Journal Of Controlled Release. Amsterdam, v. 237, p. 42-49, 2016.
ISSN 0168-3659 (Sherpa/Romeo, impact factor)
Publisher Elsevier Science Bv
Extent 42-49
Access rights Closed access
Type Article
Web of Science ID WOS:000381368300005

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account